Real-World Observational Evaluation of Hair Thinning in Patients with Multiple Sclerosis Receiving Teriflunomide: Is It an Issue in Clinical Practice?

    August 2018 in “ Neurology and Therapy ”
    Lori Hendin Travis, Annette Okai, Steve Cavalier … Keith R. Edwards
    Studysummary In this observational study, most patients with multiple sclerosis on teriflunomide who experienced hair thinning reported it as mild or moderate and largely recovered while continuing treatment.
    Automatically generated from the study's abstract, not written by a person, and not a review of the full paper. Not medical advice or a treatment recommendation. Read the original study, and consult a qualified healthcare professional before changing treatment. Full disclaimer
    Read the full study on link.springer.com →
    Discuss this study in the Community →

    Research cited in this study 7

    1. Hormonal Therapy in Female Pattern Hair Loss International Journal of Women's Dermatology · 2017
    2. Hair Camouflage: A Comprehensive Review International Journal of Women's Dermatology · 2017
    3. Transient Hair Loss During Treatment with Dimethyl Fumarate for Multiple Sclerosis Multiple sclerosis and related disorders · 2016
    4. Pooled Safety and Tolerability Data from Four Placebo-Controlled Teriflunomide Studies and Extensions Multiple Sclerosis and Related Disorders · 2015
    5. Diffuse Hair Loss: Its Triggers and Management Cleveland Clinic Journal of Medicine · 2009
    6. Multiple Sclerosis: Side Effects of Interferon Beta Therapy and Their Management Neurology · 1999
    7. Hair Camouflage: A Comprehensive Review International Journal of Women's Dermatology · 1982